As of Aug 30
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 7.66, with a high estimate of 7.66 and a low estimate of 7.66. The median estimate represents a +475.65% increase from the last price of 1.33.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.